Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0000950170-25-053382

Options or other derivatives

  • Chief Accounting Officer acquired 50,262 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Hagen Brett R · Chief Accounting Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-04-10 Grant or award : show line 1 in the form Stock Option (Right to Buy) +50,262 50,262 D
Loading xslF345X05/ownership.xml…